Abstract:Background Tumor-associated macrophages (TAMs) play key roles in the development of many malignant solid tumors including breast cancer. They are educated in the tumor microenvironment (TME) to promote tumor growth, metastasis, and therapy resistance. However, the phenotype of TAMs is elusive and how to regulate them for therapeutic purpose remains unclear; therefore, TAM-targeting therapies have not yet achieved clinical success. The purposes of this study were to examine the role of transcription factor EB (TFEB) in regulating TAM gene expression and function and to determine if TFEB activation can halt breast tumor development. Methods Microarrays were used to analyze the gene expression profile of macrophages (MΦs) in the context of breast cancer and to examine the impact of TFEB overexpression. Cell culture studies were performed to define the mechanisms by which TFEB affects MΦ gene expression and function. Mouse studies were carried out to investigate the impact of MΦ TFEB deficiency or activation on breast tumor growth. Human cancer genome data were analyzed to reveal the prognostic value of TFEB and its regulated genes. Results TAM-mimic MΦs display a unique gene expression profile, including significant reduction in TFEB expression. TFEB overexpression favorably modulates TAM gene expression through multiple signaling pathways. Specifically, TFEB upregulates suppressor of cytokine signaling 3 (SOCS3) and peroxisome proliferator-activated receptor γ (PPARγ) expression and autophagy/lysosome activities, inhibits NLRP3 (NLR Family Pyrin Domain Containing 3) inflammasome and hypoxia-inducible factor (HIF)-1α mediated hypoxia response, and thereby suppresses an array of effector molecules in TAMs including arginase 1, interleukin (IL)-10, IL-1β, IL-6 and prostaglandin E2. MΦ-specific TFEB deficiency promotes, while activation of TFEB using the natural disaccharide trehalose halts, breast tumor development by modulating TAMs. Analysis of human patient genome database reveals that expression levels of TFEB, SOCS3 and PPARγ are positive prognostic markers, while HIF-1α is a negative prognostic marker of breast cancer. Conclusions Our study identifies TFEB as a master regulator of TAMs in breast cancer. TFEB controls TAM gene expression and function through multiple autophagy/lysosome-dependent and independent pathways. Therefore, pharmacological activation of TFEB would be a promising therapeutic approach to improve the efficacy of existing treatment including immune therapies for breast cancer by favorably modulating TAM function and the TME.

Transcription factor EB coordinates environmental cues to regulate T regulatory cells' mitochondrial fitness and function.

Transcription factor EB modulates the homeostasis of reactive oxygen species in intestinal epithelial cells to alleviate inflammatory bowel disease

The Role and Regulatory Mechanism of Transcription Factor EB in Health and Diseases

Mitochondrial translocation of TFEB regulates complex I and inflammation

Integration of Transcriptional and Epigenetic Regulation of TFEB Reveals Its Dual Functional Roles in Pan-cancer

Dissecting the multifaced function of transcription factor EB (TFEB) in human diseases: From molecular mechanism to pharmacological modulation

Transcriptional factor EB regulates macrophage polarization in the tumor microenvironment

From the regulatory mechanism of TFEB to its therapeutic implications

TFEB is a master regulator of tumor-associated macrophages in breast cancer

The complex relationship between TFEB transcription factor phosphorylation and subcellular localization

The nutrient-sensing Rag-GTPase complex in B cells controls humoral immunity via TFEB/TFE3-dependent mitochondrial fitness

TGF-β and Eomes Control the Homeostasis of CD8+ Regulatory T Cells

Mitochondrial mechanisms in Treg cell regulation: Implications for immunotherapy and disease treatment

Metabolic control of TH17 and induced Treg cell balance by an epigenetic mechanism

A central role for regulated protein stability in the control of TFE3 and MITF by nutrients

Transcription Factor EB: A Potential Integrated Network Regulator in Metabolic-Associated Cardiac Injury.

Tcf1 and Lef1 Are Required for the Immunosuppressive Function of Regulatory T Cells

TFEB regulates dendritic cell antigen presentation to modulate immune balance in asthma

CXXC-finger protein 1 associates with FOXP3 to stabilize homeostasis and suppressive functions of regulatory T cells

TFEB: a double-edged sword for tumor metastasis

TSC1-mTOR-controlled Metabolic Epigenetic Crosstalk Underlies DC Control of CD8+T Cell Homeostasis